Geneos Wealth Management’s Fate Therapeutics FATE Stock Holding History

Geneos Wealth Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.27K	Hold
2025 Q2	$2.02K	Buy
2022 Q2	–	Sell
2022 Q1	$7K	Hold
2021 Q4	$11K	Buy
2021 Q3	$5K	Buy